Ollin Biosciences to Participate in Upcoming Investor Conferences
AUSTIN, Texas--(BUSINESS WIRE)--Ollin Biosciences, Inc. (Ollin), a clinical-stage biotech advancing best-in-disease therapies for vision-threatening diseases, today announced management will participate in two upcoming investor conferences: 2026 Jefferies Global Healthcare Conference 1x1 Meetings: Tuesday, June 2 New York, NY Evercore 2026 Emerging Private Biotech Conference Ophthalmology Panel: Wednesday, June 24, 8:50 a.m. ET Newport, RI About Ollin Biosciences Established in 2023, Ollin Bios